Annual Long Term Debt
$28.30 M
-$5.21 M-15.54%
December 31, 2023
Summary
- As of February 28, 2025, MRSN annual long term debt is $28.30 million, with the most recent change of -$5.21 million (-15.54%) on December 31, 2023.
- During the last 3 years, MRSN annual long term debt has risen by +$13.16 million (+86.96%).
- MRSN annual long term debt is now -21.12% below its all-time high of $35.87 million, reached on December 31, 2021.
Performance
MRSN Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$16.29 M
-$4.03 M-19.81%
September 30, 2024
Summary
- As of February 28, 2025, MRSN quarterly long term debt is $16.29 million, with the most recent change of -$4.03 million (-19.81%) on September 30, 2024.
- Over the past year, MRSN quarterly long term debt has dropped by -$14.91 million (-47.78%).
- MRSN quarterly long term debt is now -54.58% below its all-time high of $35.87 million, reached on December 31, 2021.
Performance
MRSN Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
MRSN Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -15.5% | -47.8% |
3 y3 years | +87.0% | -47.8% |
5 y5 years | +100.0% | -47.8% |
MRSN Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -21.1% | at low | -54.6% | at low |
5 y | 5-year | -21.1% | +480.1% | -54.6% | +234.0% |
alltime | all time | -21.1% | -100.0% | -54.6% | -100.0% |
Mersana Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $16.29 M(-19.8%) |
Jun 2024 | - | $20.32 M(-16.5%) |
Mar 2024 | - | $24.32 M(-14.0%) |
Dec 2023 | $28.30 M(-15.5%) | $28.30 M(-9.3%) |
Sep 2023 | - | $31.20 M(-2.5%) |
Jun 2023 | - | $32.01 M(-2.3%) |
Mar 2023 | - | $32.78 M(-2.2%) |
Dec 2022 | $33.50 M(-6.6%) | $33.50 M(-1.9%) |
Sep 2022 | - | $34.14 M(-2.0%) |
Jun 2022 | - | $34.84 M(-1.2%) |
Mar 2022 | - | $35.27 M(-1.7%) |
Dec 2021 | $35.87 M | $35.87 M(+111.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $16.98 M(-2.5%) |
Jun 2021 | - | $17.41 M(+18.2%) |
Mar 2021 | - | $14.74 M(-2.6%) |
Dec 2020 | $15.13 M(+210.3%) | $15.13 M(-2.7%) |
Sep 2020 | - | $15.55 M(+8.7%) |
Jun 2020 | - | $14.30 M(-4.8%) |
Mar 2020 | - | $15.03 M(+208.1%) |
Dec 2019 | $4.88 M(>+9900.0%) | $4.88 M(-17.7%) |
Sep 2019 | - | $5.93 M(-10.6%) |
Jun 2019 | - | $6.63 M(+179.1%) |
Mar 2019 | - | $2.38 M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Mersana Therapeutics annual long term debt?
- What is the all time high annual long term debt for Mersana Therapeutics?
- What is Mersana Therapeutics annual long term debt year-on-year change?
- What is Mersana Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly long term debt year-on-year change?
What is Mersana Therapeutics annual long term debt?
The current annual long term debt of MRSN is $28.30 M
What is the all time high annual long term debt for Mersana Therapeutics?
Mersana Therapeutics all-time high annual long term debt is $35.87 M
What is Mersana Therapeutics annual long term debt year-on-year change?
Over the past year, MRSN annual long term debt has changed by -$5.21 M (-15.54%)
What is Mersana Therapeutics quarterly long term debt?
The current quarterly long term debt of MRSN is $16.29 M
What is the all time high quarterly long term debt for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly long term debt is $35.87 M
What is Mersana Therapeutics quarterly long term debt year-on-year change?
Over the past year, MRSN quarterly long term debt has changed by -$14.91 M (-47.78%)